1. Home
  2. MYND vs CRVO Comparison

MYND vs CRVO Comparison

Compare MYND & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYND
  • CRVO
  • Stock Information
  • Founded
  • MYND 1998
  • CRVO 2001
  • Country
  • MYND Cayman Islands
  • CRVO United States
  • Employees
  • MYND N/A
  • CRVO N/A
  • Industry
  • MYND Other Consumer Services
  • CRVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYND Real Estate
  • CRVO Health Care
  • Exchange
  • MYND Nasdaq
  • CRVO Nasdaq
  • Market Cap
  • MYND 85.8M
  • CRVO 98.3M
  • IPO Year
  • MYND 2017
  • CRVO N/A
  • Fundamental
  • Price
  • MYND $1.67
  • CRVO $2.11
  • Analyst Decision
  • MYND
  • CRVO Buy
  • Analyst Count
  • MYND 0
  • CRVO 8
  • Target Price
  • MYND N/A
  • CRVO $38.75
  • AVG Volume (30 Days)
  • MYND 62.0K
  • CRVO 303.4K
  • Earning Date
  • MYND 02-05-2025
  • CRVO 11-12-2024
  • Dividend Yield
  • MYND N/A
  • CRVO N/A
  • EPS Growth
  • MYND N/A
  • CRVO N/A
  • EPS
  • MYND N/A
  • CRVO N/A
  • Revenue
  • MYND $357,050,000.00
  • CRVO $10,066,550.00
  • Revenue This Year
  • MYND N/A
  • CRVO $34.17
  • Revenue Next Year
  • MYND N/A
  • CRVO N/A
  • P/E Ratio
  • MYND N/A
  • CRVO N/A
  • Revenue Growth
  • MYND N/A
  • CRVO 116.29
  • 52 Week Low
  • MYND $0.01
  • CRVO $1.80
  • 52 Week High
  • MYND $5.57
  • CRVO $26.38
  • Technical
  • Relative Strength Index (RSI)
  • MYND 41.35
  • CRVO 28.68
  • Support Level
  • MYND $1.50
  • CRVO $2.03
  • Resistance Level
  • MYND $1.78
  • CRVO $2.17
  • Average True Range (ATR)
  • MYND 0.24
  • CRVO 0.16
  • MACD
  • MYND -0.04
  • CRVO 0.30
  • Stochastic Oscillator
  • MYND 13.39
  • CRVO 23.08

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: